BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, ...
"We are pleased to be sharing several new analyses relating to aficamten at the upcoming ACC Scientific Session & Expo,” said ...
Cytokinetics (CYTK) announced five presentations related to aficamten, an investigational cardiac myosin inhibitor, and hypertrophic ...
Presentation: First Report of Phase Ib/2a Study Evaluating Safety and Early Efficacy of TN-201, an Adeno-Associated Virus Serotype 9 Gene Replacement Therapy, in Adults with MYBPC3 -Associated ...
KLE VK Institute of Dental Sciences hosts 28th Scientific Conference showcasing student excellence in dental care innovations ...
The Meritus School of Osteopathic Medicine recently hosted its first research and scholarly activity conference, Meritus ...
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...
The 14th annual symposium on health data and Artificial Intelligence (AI) was organised by the Biomedical Informatics Unit ...
The 33rd National Laser Symposium successfully concluded at Medicaps University, Indore, bringing together scientists, ...
New Evrysdi five-year data from the SUNFISH study showed continued stabilisation of motor function in a broad population of ind ...
From June 12–13 , 2025, the 3rd Advances in Separation Science Workshop will take take place in Gembloux, Belgium.
Nadja Sayej on MSN16h
A New Technological Pinnacle: How Pavel Malinovskiy Became ‘Technology Executive of the Year’ and Is Taking Pyjam to the U.S. MarketAt the start of 2025, the name Pavel Malinovskiy once again echoed through the global tech and business landscape. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback